ASTEC

Astec LifeSciences Balance Sheet

₹742.35+5.34%
Market cap
₹1,654 crore
P/E
22.5
P/B
4.23
ROE
-25.9%
Dividend yield
1.20%

As of Mar 2022, Astec LifeSciences had total assets of ₹13,700 crore and borrowings of ₹1,200 crore, against shareholders' equity of ₹9,000 crore — a debt-to-equity ratio of 0.13. Borrowings rose 251.72% from Mar 2023.

Astec LifeSciences balance sheet

As at each financial year end, newest first. H1 = half-year.

Astec LifeSciences balance sheet (₹ crore)
ItemMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital50019.6119.6119.6122.28
Reserves8,50032627614160.69
Borrowings1,200341494555449
Other liabilities3,50021911291.86102
Total liabilities13,700979975881942
Fixed assets6,500441532498455
Capital work in progress400100100100100
Investments2,500196195176188
Other assets4,300294292264283
Total assets13,700979975881942

Balance sheet ratios

Debt to equity
0.13

Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Astec LifeSciences balance sheet — frequently asked questions

What is the total debt of Astec LifeSciences?

Astec LifeSciences reported borrowings of ₹1,200 crore as of Mar 2022, compared with ₹341 crore as of Mar 2023.

What is Astec LifeSciences' debt-to-equity ratio?

Based on the Mar 2022 balance sheet, Astec LifeSciences' debt-to-equity ratio is 0.13 — borrowings of ₹1,200 crore against equity capital and reserves of ₹9,000 crore.

What are Astec LifeSciences' total assets?

Astec LifeSciences' total assets were ₹13,700 crore as of Mar 2022, including fixed assets of ₹6,500 crore and investments of ₹2,500 crore.

Same Data For Peers

Trade Astec LifeSciences With ATS

Track ASTEC live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.